Lantern Pharma to Establish A.I. Center of Excellence in India to Scale RADR® Platform for Global Biopharma Partnerships
Lantern Pharma announced the launch of a new A.I. Center of Excellence in Bengaluru, India, aimed at industrializing its RADR® artificial intelligence platform to support large-scale data engineering, advanced machine learning disease models, and collaborations with global biopharma companies. This initiative is designed to enhance Lantern’s computational capabilities across oncology and other disease areas, accelerate AI-driven drug discovery, and expand its global partnerships while maintaining a cash-neutral impact on operations. 
Lantern Pharma to Establish A.I. Center of Excellence in India to Scale RADR® Platform for Global Biopharma Partnerships